SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001308179-23-000757
Filing Date
2023-04-24
Accepted
2023-04-24 16:31:47
Documents
47

Document Format Files

Seq Description Document Type Size
1 ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A lrare2023_def14a.htm   iXBRL DEF 14A 1239706
2 GRAPHIC check01.jpg GRAPHIC 1645
3 GRAPHIC logo.jpg GRAPHIC 14880
4 GRAPHIC lrare2023_def14ax11x1.jpg GRAPHIC 962
5 GRAPHIC lrare2023_def14ax18x1.jpg GRAPHIC 1568
6 GRAPHIC lrare2023_def14ax26x1.jpg GRAPHIC 1719
7 GRAPHIC lrare2023_def14ax2x1.jpg GRAPHIC 145843
8 GRAPHIC lrare2023_def14ax30x1.jpg GRAPHIC 1719
9 GRAPHIC lrare2023_def14ax32x1.jpg GRAPHIC 1738
10 GRAPHIC lrare2023_def14ax40x1.jpg GRAPHIC 14904
11 GRAPHIC lrare2023_def14ax4x1.jpg GRAPHIC 14145
12 GRAPHIC lrare2023_def14ax5x1.jpg GRAPHIC 9995
13 GRAPHIC lrare2023_def14ax5x2.jpg GRAPHIC 4877
14 GRAPHIC lrare2023_def14ax5x3.jpg GRAPHIC 5229
15 GRAPHIC lrare2023_def14ax5x4.jpg GRAPHIC 5663
16 GRAPHIC lrare2023_def14ax5x5.jpg GRAPHIC 5395
17 GRAPHIC lrare2023_def14ax75x1.jpg GRAPHIC 57281
18 GRAPHIC lrare2023_def14ax75x2.jpg GRAPHIC 63443
19 GRAPHIC lrare2023_def14ax75x3.jpg GRAPHIC 58565
20 GRAPHIC lrare2023_def14ax8x1.jpg GRAPHIC 1767
21 GRAPHIC lrare2023_def14ax8x2.jpg GRAPHIC 2129
22 GRAPHIC lrare2023_def14ax8x3.jpg GRAPHIC 1927
23 GRAPHIC lrare2023_def14ax97x1.jpg GRAPHIC 38038
24 GRAPHIC lrare2023_def14ax9x1.jpg GRAPHIC 1719
25 GRAPHIC lrare2023_def14ax9x2.jpg GRAPHIC 1425
26 GRAPHIC lrare2023_def14ax9x3.jpg GRAPHIC 62633
27 GRAPHIC lrarex49x1.jpg GRAPHIC 56573
28 GRAPHIC lrarex51x1.jpg GRAPHIC 58911
29 GRAPHIC lrarex52x1.jpg GRAPHIC 1778
30 GRAPHIC lrarex52x2.jpg GRAPHIC 1785
31 GRAPHIC lrarex59x1.jpg GRAPHIC 12988
32 GRAPHIC proxy1.jpg GRAPHIC 225626
33 GRAPHIC proxy2.jpg GRAPHIC 255544
34 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-23-000757.txt   4954107

Data Files

Seq Description Document Type Size
35 XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE rare-20221231_def.xml EX-101.DEF 5032
36 XBRL TAXONOMY EXTENSION - LABEL LINKBASE rare-20221231_lab.xml EX-101.LAB 18165
37 XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE rare-20221231_pre.xml EX-101.PRE 4018
38 XBRL TAXONOMY EXTENSION - SCHEMA rare-20221231.xsd EX-101.SCH 9670
41 EXTRACTED XBRL INSTANCE DOCUMENT lrare2023_def14a_htm.xml XML 120961
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36276 | Film No.: 23840493
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences